NASDAQ Volatile Stocks: Plug Power Inc (NASDAQ:PLUG), Wave Systems (NASDAQ:WAVX), Ariad Pharmaceuticals (NASDAQ:ARIA), Galena Biopharma (NASDAQ:GALE)

Finally, Zacks upgraded shares of Plug Power Inc (NASDAQ:PLUG) from a neutral rating to an outperform rating. Zacks now has a $7.90 price target on that stock. Plug Power Inc (NASDAQ:PLUG) stock performance was -4.51% in last session and finished the day at $6.99. Traded volume was 23.45million shares in the last session and the average volume of the stock remained 44.53million shares. The beta … Continue reading NASDAQ Volatile Stocks: Plug Power Inc (NASDAQ:PLUG), Wave Systems (NASDAQ:WAVX), Ariad Pharmaceuticals (NASDAQ:ARIA), Galena Biopharma (NASDAQ:GALE)

Health Stocks In New: Amgen (NASDAQ:AMGN), Novavax (NASDAQ:NVAX), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD)

Amgen Inc. (NASDAQ:AMGN) carries a Zacks Rank #1 (Strong Buy). Amgen, Inc. (NASDAQ:AMGN) stock performance was -1.90% in last session and finished the day at $111.94. Traded volume was 7.26million shares in the last session and the average volume of the stock remained 3.63million shares. The beta of the stock remained 0.51. Amgen, Inc. (NASDAQ:AMGN) insider ownership is 0.10%. Novavax, Inc. (NASDAQ:NVAX), a clinical-stage biopharmaceutical … Continue reading Health Stocks In New: Amgen (NASDAQ:AMGN), Novavax (NASDAQ:NVAX), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD)

The appointment of Hugh M. Cole as the Senior Vice President as well as Chief Business Officer of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) has been announced. He would be reporting to Chairman as well as CEO Harvey J. Berger. Cole, who has more than 25 years of experience in the pharma industry, would take up the strategic planning as well as the business development of the … Continue reading Small Cap Active Runners: Ariad Pharmaceuticals (NASDAQ:ARIA), FuelCell Energy Inc (NASDAQ:FCEL), IAMGOLD (NYSE:IAG), E Commerce China Dangdang (NYSE:DANG)

Sales of the Arena Pharmaceuticals Inc (NASDAQ:ARNA) anti-obesity drug Belviq have closed out the quarter on a positive note. Sales improved throughout the quarter and are pacing well ahead of the previous quarter. Though this week’s sales only take us to March 28th, there is enough here for us to assess the sales activity, project some revenue, and look to the pace. Arena Pharmaceuticals, Inc. … Continue reading Biotech Active runners: Arena Pharmaceuticals (NASDAQ:ARNA), Halozyme Therapeutics (NASDAQ:HALO), Gildan Activewear (NYSE:GIL), Ariad Pharmaceuticals (NASDAQ:ARIA)

MannKind Corporation (NASDAQ:MNKD) had its price objective reduced by Cowen and Company from $5.50 to $5.00 in a report released on Wednesday,Stock Ratings News reports. Analysts at Piper Jaffray downgraded shares of MannKind Corporation (NASDAQ:MNKD) from a neutral rating to an underweight rating in a research note on Monday. MannKind Corporation (NASDAQ:MNKD) stock performance was -0.86% in last session and finished the day at $6.93. … Continue reading Biotech Runners: MannKind Corporation (NASDAQ:MNKD), Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), CytRx Corporation (NASDAQ:CYTR)

Looking back to 160 days ago, ZIOPHARM Oncology Inc (NASDAQ:ZIOP) priced a 14,300,000 share secondary stock offering at $3.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Wednesday. ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) stock performance was -3.75% in last session and finished the … Continue reading Volatile Stocks at Biotech: ZIOPHARM Oncology (NASDAQ:ZIOP), Idenix Pharmaceuticals (NASDAQ:IDIX), Synthetic Biologics (NYSEMKT:SYN), Ariad Pharmaceuticals (NASDAQ:ARIA)